Hematuria medical therapy

Jump to: navigation, search

Hematuria Microchapters


Patient Information





Differentiating Hematuria from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis


Diagnostic Evaluation

History and Symptoms

Physical Examination

Laboratory Findings



Other Imaging Findings


Medical Therapy


Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hematuria medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Hematuria medical therapy

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hematuria medical therapy

CDC on Hematuria medical therapy

Hematuria medical therapy in the news

Blogs on Hematuria medical therapy

Directions to Hospitals Treating Hematuria

Risk calculators and risk factors for Hematuria medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Steven C. Campbell, M.D., Ph.D.Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]


The treatment of hematuria is driven by the underlying pathophysiology and is in large part conservative.

Medical Therapy

The initial evaluation of patients presenting with gross hematuria is 3-fold:[1]

  • Assess hemodynamic stability
  • Determine the underlying cause of hematuria (same for gross hematuria/ microscopic hematuria/ asymptomatic hematuria).[2]
  • Ensure urinary drainage.

Treatment depends on the underlying cause of hematuria, and severity of symptoms. Controlling hypertension is usually the most important part of treatment.

Medicines that may be prescribed include:

A procedure called plasmapheresis may sometimes be used for glomerulonephritis caused by immune problems. The fluid part of the blood that contains antibodies is removed and replaced with intravenous fluids or donated plasma (that does not contain antibodies). Removing antibodies may reduce inflammation in the kidney tissues.


  1. Avellino GJ, Bose S, Wang DS (2016). "Diagnosis and Management of Hematuria". Surg Clin North Am. 96 (3): 503–15. doi:10.1016/j.suc.2016.02.007. PMID 27261791.
  2. Pan, Cynthia G. (2006). "Evaluation of Gross Hematuria". Pediatric Clinics of North America. 53 (3): 401–412. doi:10.1016/j.pcl.2006.03.002. ISSN 0031-3955.